Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1995 Apr;69(4):2082–2091. doi: 10.1128/jvi.69.4.2082-2091.1995

An etoposide-induced block in vaccinia virus telomere resolution is dependent on the virus-encoded DNA ligase.

A M DeLange 1, M S Carpenter 1, J Choy 1, V E Newsway 1
PMCID: PMC188874  PMID: 7884854

Abstract

Etoposide, an inhibitor of the breakage-reunion reaction associated with cellular type II DNA topoisomerases, was shown to inhibit plaque formation of vaccinia virus. This drug had a major effect on the segregation of newly replicated DNA concatemers. Gene expression and the initiation and elongation phases of viral DNA replication were essentially unaffected. Pulsed-field gel electrophoresis of viral DNA replicated in the presence of etoposide revealed two major classes of DNA: the mature monomeric linear genome and DNA that failed to enter the gel (the relative proportions depending on the concentrations of drug). Restriction enzyme analysis showed a severe defect in telomere resolution. In addition, slowly migrating restriction fragments were suggestive of a general recombination defect. We have isolated several etoposide-resistant mutants and used marker rescue and DNA sequencing to localize the resistance-causing mutation to the amino terminus of the viral DNA ligase gene. Inactivation of the DNA ligase also resulted in an etoposide-resistant phenotype, but to a lesser extent. The telomere resolution and segregation defects were corrected both in the drug-resistant mutants and in the DNA ligase knockout mutants. Reinsertion of wild-type or mutant DNA ligase in the viral thymidine kinase locus confirmed the role of the viral DNA ligase in conferring sensitivity not only to etoposide but also to another topoisomerase II inhibitor, 4'-(9-acridinylamino) methanesulphon-m-anisidide (mAMSA). The data suggest that the nonessential DNA ligase is involved in telomere resolution, possibly as part of a general recombinase.

Full Text

The Full Text of this article is available as a PDF (701.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bachur N. R., Johnson R., Yu F., Hickey R., Applegren N., Malkas L. Antihelicase action of DNA-binding anticancer agents: relationship to guanosine-cytidine intercalator binding. Mol Pharmacol. 1993 Nov;44(5):1064–1069. [PubMed] [Google Scholar]
  2. Barnes D. E., Johnston L. H., Kodama K., Tomkinson A. E., Lasko D. D., Lindahl T. Human DNA ligase I cDNA: cloning and functional expression in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A. 1990 Sep;87(17):6679–6683. doi: 10.1073/pnas.87.17.6679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Baroudy B. M., Venkatesan S., Moss B. Incompletely base-paired flip-flop terminal loops link the two DNA strands of the vaccinia virus genome into one uninterrupted polynucleotide chain. Cell. 1982 Feb;28(2):315–324. doi: 10.1016/0092-8674(82)90349-x. [DOI] [PubMed] [Google Scholar]
  4. Beck W. T., Danks M. K., Wolverton J. S., Granzen B., Chen M., Schmidt C. A., Bugg B. Y., Friche E., Suttle D. P. Altered DNA topoisomerase II in multidrug resistance. Cytotechnology. 1993;11(2):115–119. doi: 10.1007/BF00749000. [DOI] [PubMed] [Google Scholar]
  5. Carpenter M. S., DeLange A. M. A temperature-sensitive lesion in the small subunit of the vaccinia virus-encoded mRNA capping enzyme causes a defect in viral telomere resolution. J Virol. 1991 Aug;65(8):4042–4050. doi: 10.1128/jvi.65.8.4042-4050.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Carpenter M. S., DeLange A. M. Identification of a temperature-sensitive mutant of vaccinia virus defective in late but not intermediate gene expression. Virology. 1992 May;188(1):233–244. doi: 10.1016/0042-6822(92)90753-c. [DOI] [PubMed] [Google Scholar]
  7. Chakrabarti S., Brechling K., Moss B. Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques. Mol Cell Biol. 1985 Dec;5(12):3403–3409. doi: 10.1128/mcb.5.12.3403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ciarrocchi G., Lestingi M., Fontana M., Spadari S., Montecucco A. Correlation between anthracycline structure and human DNA ligase inhibition. Biochem J. 1991 Oct 1;279(Pt 1):141–146. doi: 10.1042/bj2790141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ciarrocchi G., Lestingi M., Wright G., Montecucco A. Bacteriophage T4 and human type I DNA ligases relax DNA under joining conditions. Nucleic Acids Res. 1993 Dec 25;21(25):5934–5939. doi: 10.1093/nar/21.25.5934. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Colinas R. J., Goebel S. J., Davis S. W., Johnson G. P., Norton E. K., Paoletti E. A DNA ligase gene in the Copenhagen strain of vaccinia virus is nonessential for viral replication and recombination. Virology. 1990 Nov;179(1):267–275. doi: 10.1016/0042-6822(90)90295-3. [DOI] [PubMed] [Google Scholar]
  11. Condit R. C., Easterly R., Pacha R. F., Fathi Z., Meis R. J. A vaccinia virus isatin-beta-thiosemicarbazone resistance mutation maps in the viral gene encoding the 132-kDa subunit of RNA polymerase. Virology. 1991 Dec;185(2):857–861. doi: 10.1016/0042-6822(91)90559-t. [DOI] [PubMed] [Google Scholar]
  12. Condit R. C., Motyczka A., Spizz G. Isolation, characterization, and physical mapping of temperature-sensitive mutants of vaccinia virus. Virology. 1983 Jul 30;128(2):429–443. doi: 10.1016/0042-6822(83)90268-4. [DOI] [PubMed] [Google Scholar]
  13. Danks M. K., Warmoth M. R., Friche E., Granzen B., Bugg B. Y., Harker W. G., Zwelling L. A., Futscher B. W., Suttle D. P., Beck W. T. Single-strand conformational polymorphism analysis of the M(r) 170,000 isozyme of DNA topoisomerase II in human tumor cells. Cancer Res. 1993 Mar 15;53(6):1373–1379. [PubMed] [Google Scholar]
  14. DeLange A. M. Identification of temperature-sensitive mutants of vaccinia virus that are defective in conversion of concatemeric replicative intermediates to the mature linear DNA genome. J Virol. 1989 Jun;63(6):2437–2444. doi: 10.1128/jvi.63.6.2437-2444.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. DeLange A. M., McFadden G. The role of telomeres in poxvirus DNA replication. Curr Top Microbiol Immunol. 1990;163:71–92. doi: 10.1007/978-3-642-75605-4_3. [DOI] [PubMed] [Google Scholar]
  16. Ebert S. N., Subramanian D., Shtrom S. S., Chung I. K., Parris D. S., Muller M. T. Association between the p170 form of human topoisomerase II and progeny viral DNA in cells infected with herpes simplex virus type 1. J Virol. 1994 Feb;68(2):1010–1020. doi: 10.1128/jvi.68.2.1010-1020.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Elder R. H., Montecucco A., Ciarrocchi G., Rossignol J. M. Rat liver DNA ligases. Catalytic properties of a novel form of DNA ligase. Eur J Biochem. 1992 Jan 15;203(1-2):53–58. doi: 10.1111/j.1432-1033.1992.tb19826.x. [DOI] [PubMed] [Google Scholar]
  18. Esposito J., Condit R., Obijeski J. The preparation of orthopoxvirus DNA. J Virol Methods. 1981 Feb;2(3):175–179. doi: 10.1016/0166-0934(81)90036-7. [DOI] [PubMed] [Google Scholar]
  19. Goebel S. J., Johnson G. P., Perkus M. E., Davis S. W., Winslow J. P., Paoletti E. The complete DNA sequence of vaccinia virus. Virology. 1990 Nov;179(1):247-66, 517-63. doi: 10.1016/0042-6822(90)90294-2. [DOI] [PubMed] [Google Scholar]
  20. Hu F. Q., Pickup D. J. Transcription of the terminal loop region of vaccinia virus DNA is initiated from the telomere sequences directing DNA resolution. Virology. 1991 Apr;181(2):716–720. doi: 10.1016/0042-6822(91)90905-q. [DOI] [PubMed] [Google Scholar]
  21. Huff A. C., Leatherwood J. K., Kreuzer K. N. Bacteriophage T4 DNA topoisomerase is the target of antitumor agent 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) in T4-infected Escherichia coli. Proc Natl Acad Sci U S A. 1989 Feb;86(4):1307–1311. doi: 10.1073/pnas.86.4.1307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Huff A. C., Ward R. E., 4th, Kreuzer K. N. Mutational alteration of the breakage/resealing subunit of bacteriophage T4 DNA topoisomerase confers resistance to antitumor agent m-AMSA. Mol Gen Genet. 1990 Mar;221(1):27–32. doi: 10.1007/BF00280363. [DOI] [PubMed] [Google Scholar]
  23. Jannatipour M., Liu Y. X., Nitiss J. L. The top2-5 mutant of yeast topoisomerase II encodes an enzyme resistant to etoposide and amsacrine. J Biol Chem. 1993 Sep 5;268(25):18586–18592. [PubMed] [Google Scholar]
  24. Keck J. G., Baldick C. J., Jr, Moss B. Role of DNA replication in vaccinia virus gene expression: a naked template is required for transcription of three late trans-activator genes. Cell. 1990 Jun 1;61(5):801–809. doi: 10.1016/0092-8674(90)90190-p. [DOI] [PubMed] [Google Scholar]
  25. Kerr S. M., Johnston L. H., Odell M., Duncan S. A., Law K. M., Smith G. L. Vaccinia DNA ligase complements Saccharomyces cerevisiae cdc9, localizes in cytoplasmic factories and affects virulence and virus sensitivity to DNA damaging agents. EMBO J. 1991 Dec;10(13):4343–4350. doi: 10.1002/j.1460-2075.1991.tb05012.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Kerr S. M., Smith G. L. Vaccinia virus DNA ligase is nonessential for virus replication: recovery of plasmids from virus-infected cells. Virology. 1991 Feb;180(2):625–632. doi: 10.1016/0042-6822(91)90076-n. [DOI] [PubMed] [Google Scholar]
  27. Kerr S. M., Smith G. L. Vaccinia virus encodes a polypeptide with DNA ligase activity. Nucleic Acids Res. 1989 Nov 25;17(22):9039–9050. doi: 10.1093/nar/17.22.9039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Kodama K., Barnes D. E., Lindahl T. In vitro mutagenesis and functional expression in Escherichia coli of a cDNA encoding the catalytic domain of human DNA ligase I. Nucleic Acids Res. 1991 Nov 25;19(22):6093–6099. doi: 10.1093/nar/19.22.6093. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Lindahl T., Barnes D. E. Mammalian DNA ligases. Annu Rev Biochem. 1992;61:251–281. doi: 10.1146/annurev.bi.61.070192.001343. [DOI] [PubMed] [Google Scholar]
  30. Liu L. F. DNA topoisomerase poisons as antitumor drugs. Annu Rev Biochem. 1989;58:351–375. doi: 10.1146/annurev.bi.58.070189.002031. [DOI] [PubMed] [Google Scholar]
  31. Merchlinsky M., Moss B. Nucleotide sequence required for resolution of the concatemer junction of vaccinia virus DNA. J Virol. 1989 Oct;63(10):4354–4361. doi: 10.1128/jvi.63.10.4354-4361.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Merchlinsky M., Moss B. Resolution of vaccinia virus DNA concatemer junctions requires late-gene expression. J Virol. 1989 Apr;63(4):1595–1603. doi: 10.1128/jvi.63.4.1595-1603.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Merchlinsky M. Mutational analysis of the resolution sequence of vaccinia virus DNA: essential sequence consists of two separate AT-rich regions highly conserved among poxviruses. J Virol. 1990 Oct;64(10):5029–5035. doi: 10.1128/jvi.64.10.5029-5035.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Moss B. Regulation of vaccinia virus transcription. Annu Rev Biochem. 1990;59:661–688. doi: 10.1146/annurev.bi.59.070190.003305. [DOI] [PubMed] [Google Scholar]
  35. Moyer R. W., Graves R. L. The mechanism of cytoplasmic orthopoxvirus DNA replication. Cell. 1981 Dec;27(2 Pt 1):391–401. doi: 10.1016/0092-8674(81)90422-0. [DOI] [PubMed] [Google Scholar]
  36. Nishiyama Y., Fujioka H., Tsurumi T., Yamamoto N., Maeno K., Yoshida S., Shimokata K. Effects of the epipodophyllotoxin VP-16-213 on herpes simplex virus type 2 replication. J Gen Virol. 1987 Mar;68(Pt 3):913–918. doi: 10.1099/0022-1317-68-3-913. [DOI] [PubMed] [Google Scholar]
  37. Parks R. J., Lichty B. D., Karakis C., Evans D. H. Characterization of the Shope fibroma virus DNA ligase gene. Virology. 1994 Aug 1;202(2):642–650. doi: 10.1006/viro.1994.1385. [DOI] [PubMed] [Google Scholar]
  38. Parsons B. L., Pickup D. J. Transcription of orthopoxvirus telomeres at late times during infection. Virology. 1990 Mar;175(1):69–80. doi: 10.1016/0042-6822(90)90187-v. [DOI] [PubMed] [Google Scholar]
  39. Pennington T. H., Follett E. A. Vaccinia virus replication in enucleate BSC-1 cells: particle production and synthesis of viral DNA and proteins. J Virol. 1974 Feb;13(2):488–493. doi: 10.1128/jvi.13.2.488-493.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Prescott D. M., Kates J., Kirkpatrick J. B. Replication of vaccinia virus DNA in enucleated L-cells. J Mol Biol. 1971 Aug 14;59(3):505–508. doi: 10.1016/0022-2836(71)90313-5. [DOI] [PubMed] [Google Scholar]
  41. Reddy M. K., Bauer W. R. Activation of the vaccinia virus nicking-joining enzyme by trypsinization. J Biol Chem. 1989 Jan 5;264(1):443–449. [PubMed] [Google Scholar]
  42. Richter A., Strausfeld U., Knippers R. Effects of VM26 (teniposide), a specific inhibitor of type II DNA topoisomerase, on SV40 DNA replication in vivo. Nucleic Acids Res. 1987 Apr 24;15(8):3455–3468. doi: 10.1093/nar/15.8.3455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Schaack J., Schedl P., Shenk T. Topoisomerase I and II cleavage of adenovirus DNA in vivo: both topoisomerase activities appear to be required for adenovirus DNA replication. J Virol. 1990 Jan;64(1):78–85. doi: 10.1128/jvi.64.1.78-85.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Shaffer R., Traktman P. Vaccinia virus encapsidates a novel topoisomerase with the properties of a eucaryotic type I enzyme. J Biol Chem. 1987 Jul 5;262(19):9309–9315. [PubMed] [Google Scholar]
  46. Shuman S., Moss B. Identification of a vaccinia virus gene encoding a type I DNA topoisomerase. Proc Natl Acad Sci U S A. 1987 Nov;84(21):7478–7482. doi: 10.1073/pnas.84.21.7478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Skinner M. A., Moore J. B., Binns M. M., Smith G. L., Boursnell M. E. Deletion of fowlpox virus homologues of vaccinia virus genes between the 3 beta-hydroxysteroid dehydrogenase (A44L) and DNA ligase (A50R) genes. J Gen Virol. 1994 Sep;75(Pt 9):2495–2498. doi: 10.1099/0022-1317-75-9-2495. [DOI] [PubMed] [Google Scholar]
  48. Smith G. L., Chan Y. S., Kerr S. M. Transcriptional mapping and nucleotide sequence of a vaccinia virus gene encoding a polypeptide with extensive homology to DNA ligases. Nucleic Acids Res. 1989 Nov 25;17(22):9051–9062. doi: 10.1093/nar/17.22.9051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Snapka R. M., Powelson M. A., Strayer J. M. Swiveling and decatenation of replicating simian virus 40 genomes in vivo. Mol Cell Biol. 1988 Feb;8(2):515–521. doi: 10.1128/mcb.8.2.515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Stuart D., Graham K., Schreiber M., Macaulay C., McFadden G. The target DNA sequence for resolution of poxvirus replicative intermediates is an active late promoter. J Virol. 1991 Jan;65(1):61–70. doi: 10.1128/jvi.65.1.61-70.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Traktman P. The enzymology of poxvirus DNA replication. Curr Top Microbiol Immunol. 1990;163:93–123. doi: 10.1007/978-3-642-75605-4_4. [DOI] [PubMed] [Google Scholar]
  52. Vos J. C., Stunnenberg H. G. Derepression of a novel class of vaccinia virus genes upon DNA replication. EMBO J. 1988 Nov;7(11):3487–3492. doi: 10.1002/j.1460-2075.1988.tb03224.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Wong M. L., Hsu M. T. Involvement of topoisomerases in replication, transcription, and packaging of the linear adenovirus genome. J Virol. 1990 Feb;64(2):691–699. doi: 10.1128/jvi.64.2.691-699.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Yang L., Wold M. S., Li J. J., Kelly T. J., Liu L. F. Roles of DNA topoisomerases in simian virus 40 DNA replication in vitro. Proc Natl Acad Sci U S A. 1987 Feb;84(4):950–954. doi: 10.1073/pnas.84.4.950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Zhang Y., Keck J. G., Moss B. Transcription of viral late genes is dependent on expression of the viral intermediate gene G8R in cells infected with an inducible conditional-lethal mutant vaccinia virus. J Virol. 1992 Nov;66(11):6470–6479. doi: 10.1128/jvi.66.11.6470-6479.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES